Understanding Lung Cancer Survival in Boston
The Boston Lung Cancer Survival Cohort
This project gathers information from over 12,000 lung cancer patients to better understand the disease and improve treatments.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University D/b/a Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11094017 on NIH RePORTER |
What this research studies
This long-running project collects health information and biological samples from thousands of lung cancer patients in the Boston area. By studying this rich collection of data, researchers aim to uncover why lung cancer affects people differently and how treatments can be made more effective. The goal is to identify new ways to predict how the disease will progress and to develop better strategies for care. This work has already led to important discoveries that have changed how certain lung cancers are treated, such as linking specific genetic changes to treatment responses. The project also plans to create detailed databases using advanced imaging to further enhance our understanding of the disease.
Who could benefit from this research
Good fit: This cohort focuses on individuals diagnosed with lung cancer, particularly those who have received care at Massachusetts General Hospital and Dana-Farber Cancer Institute since 1992.
Not a fit: Patients without a lung cancer diagnosis would not directly benefit from this specific cohort's findings.
Why it matters
Potential benefit: If successful, this work could lead to more personalized and effective treatments for lung cancer patients, improving their chances of survival and quality of life.
How similar studies have performed: This established cohort has already led to significant discoveries, such as identifying genetic mutations linked to treatment response, demonstrating its successful approach.
Where this research is happening
Boston, United States
- Harvard University D/b/a Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Christiani, David C — Harvard University D/b/a Harvard School of Public Health
- Study coordinator: Christiani, David C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.